Russell Investments Group’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $179K | Sell |
15,750
-369
| -2% | -$4.19K | ﹤0.01% | 2680 |
|
|
2025
Q1 | $107K | Buy |
+16,119
| New | +$107K | ﹤0.01% | 2736 |
|
|
2024
Q3 | – | Sell |
-1,527
| Closed | -$20.6K | – | 3797 |
|
|
2024
Q2 | $20.6K | Buy |
+1,527
| New | +$20.6K | ﹤0.01% | 2933 |
|
|
2023
Q3 | – | Sell |
-1,382
| Closed | -$14.7K | – | 3621 |
|
|
2023
Q2 | $14.7K | Hold |
1,382
| – | – | ﹤0.01% | 2897 |
|
|
2023
Q1 | $11.5K | Hold |
1,382
| – | – | ﹤0.01% | 2865 |
|
|
2022
Q4 | $12.8K | Hold |
1,382
| – | – | ﹤0.01% | 2834 |
|
|
2022
Q3 | $17K | Sell |
1,382
-788
| -36% | -$9.69K | ﹤0.01% | 2823 |
|
|
2022
Q2 | $28K | Buy |
+2,170
| New | +$28K | ﹤0.01% | 2773 |
|
|
2022
Q1 | – | Sell |
-13,313
| Closed | -$319K | – | 2920 |
|
|
2021
Q4 | $319K | Buy |
+13,313
| New | +$319K | ﹤0.01% | 2588 |
|